- Title
- Clinical Trial Protocol for ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
- Creators
- Alexander B. Olawaiye - University of PittsburghJae-Weon Kim - Seoul National UniversityAndrea Bagameri - National Institute of OncologyErin Bishop - Medical College of WisconsinAnita Chudecka-Glaz - Pomeranian Medical UniversityAlix Devaux - Grand Charleroi HospitalLaurence Gladieff - Institut Claudius RegaudMary E. Gordinier - Norton HealthcareJacob Korach - Sheba Medical CenterMichael E. McCollum - Virginia Oncology AssociatesLinda Mileshkin - Peter MacCallum Cancer CentreBradley J. Monk - Gynecologic Oncology GroupShibani Nicum - University College LondonAngélica Nogueira-Rodrigues - Universidade Federal de Minas GeraisAna Oaknin - Vall d'Hebron Hospital UniversitariDavid M. O’Malley - Gynecologic Oncology GroupMauro Orlando - Instituto Alexander FlemingLyndah Dreiling - Corcept TherapeuticsIulia C. Tudor - Corcept TherapeuticsDomenica Lorusso - Agostino Gemelli University Polyclinic
- Publication Details
- Journal of gynecologic oncology, Vol.35
- Identifiers
- 991006100645802656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Clinical Trial Protocol for ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
Journal of gynecologic oncology, Vol.35
2024
Metrics
1 Record Views